1 / 40

Program Goals

Advances in Multiple Myeloma: Data Highlights and Analysis from the 2015 Hematology/Oncology Conferences. Program Goals. Newly Diagnosed Multiple Myeloma. Current Approaches for Newly Diagnosed Multiple Myeloma (MM). Importance of Fitness in Older Patients With MM.

gitel
Download Presentation

Program Goals

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Advances in Multiple Myeloma: Data Highlights and Analysis from the 2015 Hematology/Oncology Conferences

  2. Program Goals

  3. Newly Diagnosed Multiple Myeloma

  4. Current Approaches for Newly Diagnosed Multiple Myeloma (MM)

  5. Importance of Fitness in Older Patients With MM

  6. Future Directions in Treatment of Newly Diagnosed MM

  7. Relapsed/Refractory Multiple Myeloma (R/R MM)

  8. PANORAMA 1 Bortezomib/Dexamethasone ± Panobinostat

  9. ASPIRE Carfilzomib, Lenalidomide, Dexamethasone (KRd) vs Len/Dex (Rd)

  10. ENDEAVORCarfilzomib/Dexamethasone (Kd) vs Bortezomib/Dexamethasone (Vd) in Patients With 1-3 Prior Lines of Therapy

  11. Monoclonal Antibodies in Multiple Myeloma

  12. ELOQUENT-2 Len/Dex ± Elotuzumab (anti-SLAMF7) in Relapsed/Refractory MM

  13. SIRIUS Phase 2 Study of Daratumumab (anti-CD38) in Heavily Pretreated MM

  14. Monoclonal Antibodies in MM Future Directions

  15. New Targets in Multiple Myeloma

  16. Novel Proteasome Inhibitors in Development

  17. Novel Targeted Therapy Approaches in MM

  18. Novel Approaches to MM Therapy

  19. Biological Profiling of Multiple Myeloma

  20. Current Role of CytogeneticsPrognostic Information

  21. Measuring MRD in MM

  22. MM is Heterogeneous in its Genetics

  23. Summary Multiple Myeloma in 2015

  24. Abbreviations

  25. Abbreviations (cont)

  26. Abbreviations (cont)

  27. References

  28. References (cont)

  29. References (cont)

  30. References (cont)

  31. References (cont)

  32. References (cont)

  33. References (cont)

  34. References (cont)

  35. References (cont)

  36. References (cont)

  37. References (cont)

  38. References (cont)

  39. References (cont)

More Related